Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue
Anti-Müllerian hormone (AMH) is responsible for the Müllerian ducts’ regression in male fetuses. In cells of cancers with AMH receptors (AMHRII), AMH induces cell cycle arrest or apoptosis. As AMH occurs naturally and does not exhibit significant side effects while reducing neoplastic cell colonies,...
Main Authors: | Marek Gowkielewicz, Aleksandra Lipka, Marta Majewska, Aleksandra Piotrowska, Marta Szadurska-Noga, Jacek J. Nowakowski, Marta Wiszpolska, Piotr Dzięgiel, Tomasz Wasniewski, Mariusz Krzysztof Majewski, Marcin Jozwik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/10/2312 |
Similar Items
-
Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue
by: Marek Gowkielewicz, et al.
Published: (2019-03-01) -
Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles
by: Cheng-Hsuan Wu, et al.
Published: (2019-03-01) -
Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis
by: Noel Pabalan, et al.
Published: (2016-11-01) -
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer
by: Jean-Marc Barret, et al.
Published: (2021-04-01) -
Plasma anti-müllerian hormone allows reproductive selection of donors with greater potential of embryo production
by: Baruselli PS, et al.
Published: (2016-08-01)